// App-Quantinova.ai

626 : Mechanistic differentiation of targeted DDR agent combinations

Researchers

Presenter

  • Josep V. Forment

Principal Investigators

  • Paul Wijnhoven

  • Antonio Ramos-Montoya

  • Jacqueline Fok

  • Valeria Follia

  • Mercedes Vazquez-Chantada

  • Rajesh Oderda

  • Zena Wilson

  • Alan Lau

  • Elisabetta Leo

  • Stephen Durant

  • Elaine Cadogan

  • Mark J. O'Connor

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

  • Hormone receptor

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • Olaparib

  • AZD0156

  • AZD6738

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved